These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Ocular problems in HIV and AIDS patients in Nigeria.
    Author: Emina MO, Odjimogho SE.
    Journal: Optom Vis Sci; 2010 Dec; 87(12):979-84. PubMed ID: 21099441.
    Abstract:
    PURPOSE: To investigate ocular disease and visual acuity defects in patients with HIV/AIDS according to CD4T-cells counts. METHODS: The CD4T lymphocyte counts of all the volunteers were obtained. Visual acuity, refraction, ophthalmoscope, and slitlamp examinations were performed on each patient after the CD4T-cell count result was obtained. RESULTS: Young adults aged between 21 and 30 years were mostly affected, 39 (97.5%) of the HIV patients had refractive errors, and 10 (25%) had reduced vision. Seven (17.5%) moderate and one (2.5%) severe low vision patients were found between 499 to 0 and 299 to 200 CD4T-cell counts, respectively. Ocular diseases found in various CD4T-cells counts were proptosis (2.5%), orbital cellulitis (2.5%), and cytomegalovirus retinitis (2.5%) in 99 to 0, keratoconjunctivitis sicca (2.5%) and corneal keratitis (2.5%) in 499 to 400, molluscum contagiosum (2.5%) in 299 to 200, iridocyclitis (2.5%) in 199 to 100, cloudy media (22.5%), red eyes (30%), poor pupillary reflexes (17.5%), and painful eye (30%) in 499 to 0, retinal exudates (15%), disc edema (30%), and choroidoretinitis (15%) in 399 to 0, ocular toxoplasmosis (5%) and herpes zoster (7.5%) in 299 to 100, Kaposi sarcoma (12.5%) in 199 to 0, conjunctivitis (7.5%) in 499 to 300, and uveitis (7.5%) in 399 to 200. There were significant differences between visual acuity of the control and the HIV/AIDS patients, p < 0.05. CONCLUSIONS: Ocular impairments increased with decrease in CD4T-cells counts. Additional studies are required in predicting the CD4T-cells counts that will serve as a marker for specific ocular disease manifestation in HIV/AIDS.
    [Abstract] [Full Text] [Related] [New Search]